-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At 5 o'clock yesterday, GSK China announced that Zhu Ning will serve as vice president, head of market access and commercial operations, effective from June 15th, and a member of the leadership team of GSK China's prescription drugs and vaccines department, based in Shanghai.
At the same time, GSK China also announced that Wang Xinguang, the current vice president and head of CAMAC, will be appointed as the vice president, head of corporate communications and government affairs, effective from June 15th, and will be based in Shanghai.
The above was reported to Qi Xin, Vice President of GSK and General Manager of China Prescription Drugs and Vaccines.